Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Gemcitabine in Metastatic Bladder Cancer
NCT04039867Phase 2Terminated
- Sponsor
- University of California, Irvine
- Start
- Jan 2005
- Primary completion
- Oct 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin in bladder cancer, sponsored by University of California, Irvine. Primary endpoint: Treatment-emergent Adverse Events at 1 year. Started Jan 2005; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT04039867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04039867.